Amrize (NYSE:AMRZ – Get Free Report) had its target price upped by equities research analysts at UBS Group from $53.00 to $57.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price target would indicate a potential downside of 0.62% from the stock’s previous close.
A number of other equities research analysts also recently issued reports on the company. Kepler Capital Markets upgraded Amrize to a “strong-buy” rating in a research report on Tuesday, October 21st. Wall Street Zen raised Amrize to a “hold” rating in a report on Saturday, October 25th. Oddo Bhf initiated coverage on Amrize in a research report on Monday, November 3rd. They set a “neutral” rating for the company. Morgan Stanley set a $61.00 price objective on shares of Amrize and gave the stock an “overweight” rating in a research report on Wednesday, October 29th. Finally, Wells Fargo & Company raised their target price on shares of Amrize from $57.00 to $58.00 and gave the company an “overweight” rating in a research note on Thursday, October 30th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $60.73.
Check Out Our Latest Analysis on AMRZ
Amrize Trading Up 3.8%
Amrize (NYSE:AMRZ – Get Free Report) last posted its earnings results on Wednesday, October 29th. The company reported $0.98 earnings per share for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). The company had revenue of $3.68 billion for the quarter, compared to analyst estimates of $3.49 billion. The business’s revenue for the quarter was up 6.6% on a year-over-year basis.
Insider Transactions at Amrize
In other Amrize news, CEO Jan Philipp Jenisch purchased 55,000 shares of the firm’s stock in a transaction on Thursday, October 30th. The shares were purchased at an average cost of $52.64 per share, with a total value of $2,895,200.00. Following the completion of the purchase, the chief executive officer owned 1,505,000 shares of the company’s stock, valued at $79,223,200. The trade was a 3.79% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CTO Roald Brouwer acquired 4,000 shares of the stock in a transaction dated Friday, October 31st. The stock was acquired at an average price of $51.77 per share, with a total value of $207,080.00. Following the completion of the acquisition, the chief technology officer owned 9,000 shares in the company, valued at approximately $465,930. The trade was a 80.00% increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have purchased 65,000 shares of company stock worth $3,399,720.
Hedge Funds Weigh In On Amrize
Several institutional investors and hedge funds have recently made changes to their positions in AMRZ. State of Wyoming bought a new stake in Amrize in the third quarter worth $32,000. US Bancorp DE purchased a new position in shares of Amrize in the third quarter worth about $38,000. Costello Asset Management INC bought a new stake in shares of Amrize in the 3rd quarter valued at about $44,000. Global Retirement Partners LLC bought a new stake in shares of Amrize in the 3rd quarter valued at about $48,000. Finally, Jones Financial Companies Lllp purchased a new stake in Amrize during the 3rd quarter valued at about $53,000.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Articles
- Five stocks we like better than Amrize
- Wall Street Stockpicker Names #1 Stock of 2026
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Claim Your Share of $5.39 BILLION in AI Equity Checks
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
